相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Natural killer cells target and differentiate cancer stem-like cells/undifferentiated tumors: strategies to optimize their growth and expansion for effective cancer immunotherapy
Kawaljit Kaur et al.
CURRENT OPINION IN IMMUNOLOGY (2018)
How do we manufacture clinical-grade interleukin-15-stimulated natural killer cell products for cancer treatment?
Lucia Fernandez et al.
TRANSFUSION (2018)
Targeting CD138-/CD20+Clonogenic Myeloma Precursor Cells Decreases These Cells and Induces Transferable Antimyeloma Immunity
Lawrence G. Lum et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Human cancer cells with stem cell-like phenotype exhibit enhanced sensitivity to the cytotoxicity of IL-2 and IL-15 activated natural killer cells
Tao Yin et al.
CELLULAR IMMUNOLOGY (2016)
Ex vivo expansion of natural killer cells from human peripheral blood mononuclear cells co-stimulated with anti-CD3 and anti-CD52 monoclonal antibodies
Jun-ichi Masuyama et al.
CYTOTHERAPY (2016)
Expanded and armed natural killer cells for cancer treatment
Noriko Shimasaki et al.
CYTOTHERAPY (2016)
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
Shaji Kumar et al.
LANCET ONCOLOGY (2016)
The iron chelator deferasirox induces apoptosis by targeting oncogenic Pyk2/β-catenin signaling in human multiple myeloma
Yusuke Kamihara et al.
ONCOTARGET (2016)
An Integrated Analysis of the Genome-Wide Profiles of DNA Methylation and mRNA Expression Defining the Side Population of a Human Malignant Mesothelioma Cell Line
Myung-Chul Kim et al.
JOURNAL OF CANCER (2016)
Dysregulation of Chemokine/Chemokine Receptor Axes and NK Cell Tissue Localization during Diseases
Giovanni Bernardini et al.
FRONTIERS IN IMMUNOLOGY (2016)
Natural Killer Cells for immunotherapy-Advantages of the NK-92 Cell Line over Blood NK Cells
Hans Klingemann et al.
FRONTIERS IN IMMUNOLOGY (2016)
Novel treatment strategy with autologous activated and expanded natural killer cells plus anti-myeloma drugs for multiple myeloma
Alejandra Leivas et al.
ONCOIMMUNOLOGY (2016)
Side Population Cell Level in Human Breast Cancer and Factors Related to Disease-free Survival
C.G. Jin et al.
Asian Pacific Journal of Cancer Prevention (2015)
Role of Immune Therapies for Myeloma
Jacalyn Rosenblatt et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2015)
Metastatic colon cancer cell populations contain more cancer stem-like cells with a higher susceptibility to natural killer cell-mediated lysis compared with primary colon cancer cells
Ga Rim Kim et al.
ONCOLOGY LETTERS (2015)
Cytokine-induced killer cells efficiently kill stem-like cancer cells of nasopharyngeal carcinoma via the NKG2D-ligands recognition
Fang Wei et al.
ONCOTARGET (2015)
Cancer stem cells are the cause of drug resistance in multiple myeloma: fact or fiction?
Reinaldo Franqui-Machin et al.
ONCOTARGET (2015)
Dynamic balance of multiple myeloma clonogenic side population cell percentages controlled by environmental conditions
Jianguo Wen et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Transcriptome analysis reveals molecular profiles associated with evolving steps of monoclonal gammopathies
Lucia Lopez-Corral et al.
HAEMATOLOGICA (2014)
Intracellular autofluorescence: a biomarker for epithelial cancer stem cells
Irene Miranda-Lorenzo et al.
NATURE METHODS (2014)
Phenotypic, Genomic and Functional Characterization Reveals No Differences between CD138++ and CD138low Subpopulations in Multiple Myeloma Cell Lines
Teresa Paino et al.
PLOS ONE (2014)
Concise Review: Defining and Targeting Myeloma Stem Cell-Like Cells
Masahiro Abe et al.
STEM CELLS (2014)
ALDH1-Positive Cancer Stem Cells Predict Engraftment of Primary Breast Tumors and Are Governed by a Common Stem Cell Program
Emmanuelle Charafe-Jauffret et al.
CANCER RESEARCH (2013)
Bortezomib Reduces the Tumorigenicity of Multiple Myeloma via Downregulation of Upregulated Targets in Clonogenic Side Population Cells
Miho Nara et al.
PLOS ONE (2013)
Drug resistance in multiple myeloma: latest findings and new concepts on molecular mechanisms
Jahangir Abdi et al.
ONCOTARGET (2013)
Monitoring NK cell activity in patients with hematological malignancies
Sebastien Viel et al.
ONCOIMMUNOLOGY (2013)
Chemotherapy-elicited upregulation of NKG2D and DNAM-1 ligands as a therapeutic target in multiple myeloma
Alessandra Soriani et al.
ONCOIMMUNOLOGY (2013)
Characterization of potential CD138 negative myeloma stem cells
Jacob H. Christensen et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Natural killer cell lines preferentially kill clonogenic multiple myeloma cells and decrease myeloma engraftment in a bioluminescent xenograft mouse model
Brenna E. Swift et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Highly activated and expanded natural killer cells for multiple myeloma immunotherapy
Tarun K. Garg et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
CD19-CD45low/-CD38high/CD138+ plasma cells enrich for human tumorigenic myeloma cells
D. Kim et al.
LEUKEMIA (2012)
Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications
Jana Jakubikova et al.
BLOOD (2011)
Multiple Myeloma: A Paradigm for Translation of the Cancer Stem Cell Hypothesis
Jasmin Roya Agarwal et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2010)
Clonogenic assays measure leukemia stem cell killing not detectable by chromium release and flow cytometric cytotoxicity assays
Brent A. Williams et al.
CYTOTHERAPY (2010)
Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance
William Matsui et al.
CANCER RESEARCH (2008)
Knockdown of Oct-4 or Sox-2 attenuates neurogenesis of mouse embryonic stem cells
Stephen Chen et al.
STEM CELLS AND DEVELOPMENT (2007)
Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells
Maria M. Ho et al.
CANCER RESEARCH (2007)
Immunodeficiency and immunotherapy in multiple myeloma
Guy Pratt et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Characterization of a side population of cancer cells from human gastrointestinal system
Naotsugu Haraguchi et al.
STEM CELLS (2006)
分享论文
